BidaskClub downgraded shares of Utah Medical Products (NASDAQ:UTMD) from a buy rating to a hold rating in a research note released on Tuesday, BidAskClub reports.
Shares of NASDAQ:UTMD opened at $93.05 on Tuesday. Utah Medical Products has a one year low of $73.98 and a one year high of $102.70. The company has a 50 day moving average of $90.23 and a 200-day moving average of $86.95. The stock has a market cap of $347.19 million, a price-to-earnings ratio of 25.43 and a beta of 0.83.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 3rd. Stockholders of record on Friday, September 13th will be given a dividend of $0.275 per share. This represents a $1.10 annualized dividend and a dividend yield of 1.18%. The ex-dividend date is Thursday, September 12th.
Large investors have recently modified their holdings of the company. Bessemer Group Inc. grew its position in shares of Utah Medical Products by 3.4% during the 2nd quarter. Bessemer Group Inc. now owns 12,200 shares of the medical instruments supplier’s stock worth $1,168,000 after buying an additional 400 shares during the period. Geode Capital Management LLC grew its position in shares of Utah Medical Products by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 49,707 shares of the medical instruments supplier’s stock worth $4,128,000 after buying an additional 1,422 shares during the period. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Utah Medical Products during the 1st quarter worth approximately $224,000. Rice Hall James & Associates LLC grew its position in shares of Utah Medical Products by 73.5% during the 2nd quarter. Rice Hall James & Associates LLC now owns 78,053 shares of the medical instruments supplier’s stock worth $7,470,000 after buying an additional 33,064 shares during the period. Finally, Raymond James & Associates grew its position in shares of Utah Medical Products by 10.0% during the 1st quarter. Raymond James & Associates now owns 16,979 shares of the medical instruments supplier’s stock worth $1,498,000 after buying an additional 1,542 shares during the period. Institutional investors own 78.83% of the company’s stock.
About Utah Medical Products
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.
Featured Article: Why is the price target of stocks important?
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.